Results 71 to 80 of about 5,700 (203)

B3GNT2, GPR35, PSMG1 Gene Polymorphisms Are Related With Susceptibility and Severity of Ankylosing Spondylitis in Chinese Han Population

Molecular Genetics &Genomic Medicine, Volume 13, Issue 8, August 2025.
B3GNT2, GPR35, and PSMG1genes are related to ankylosing spondylitis in the Chinese Han population. ABSTRACT Background Latest research on ankylosing spondylitis (AS) indicates a link between the B3GNT2, PSMG1 genes and susceptibility to AS among western populations.
Zijian Lian, Bin Zhao, Wei Luo, Jun Liu, Jing Wang, Wei Chai, Yan Wang, Songqing Ye, Xinlong Ma   +8 more
wiley   +1 more source

Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis

Arthritis &Rheumatology, Volume 77, Issue 6, Page 658-663, June 2025.
Objective In rheumatoid arthritis (RA) and spondyloarthritis (SpA), managing persistent pain remains challenging. Little is known regarding impaired pain pathways in these patients and the impact of biologic disease‐modifying antirheumatic drugs (bDMARDs).
Anne‐Priscille Trouvin, Arielle Simunek, Joël Coste, Terkia Medkour, Alice Combier, Lucile Poiroux, François Vidal, Sandrine Carvès, Didier Bouhassira, Serge Perrot   +9 more
wiley   +1 more source

Disease Activity and Patient-Reported Health Measures in Relation to Cytokine Levels in Ankylosing Spondylitis

Rheumatology and Therapy, 2019
Introduction Ankylosing spondylitis (AS) is a lifelong condition where spinal inflammation causes chronic back pain and restriction of spinal function.
Johannes C. Nossent, Sylvia Sagen-Johnsen, Gunnstein Bakland   +2 more
doaj   +1 more source

Real‐World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease

International Journal of Rheumatic Diseases, Volume 28, Issue 5, May 2025.
ABSTRACT Aim The objective was to evaluate biologic disease‐modifying antirheumatic drugs (DMARDs) and their side effects that hindered the continuation of treatment in a patient population diagnosed with spondyloarthritis (SpA) with a glomerular filtration rate (GFR) ≤ 60 mL/min, and to compare these side effects between patients with chronic kidney ...
Dilara Bulut Gökten, Mehmet Engin Tezcan, Burcu Yağız, Abdulsamet Erden, Gezmiş Kimyon, Nazife Şule Yaşar Bilge, Levent Kılıç, Belkıs Nihan Coşkun, Emine Duygu Ersözlü, Orhan Küçükşahin, Süleyman Serdar Koca, Emel Gönüllü, Muhammet Çınar, Servet Akar, Hakan Emmungil, Timuçin Kaşifoğlu, Cemal Bes, Aşkın Ateş, Yavuz Pehlivan, Sedat Kiraz, Ali İhsan Ertenli, Hüseyin Ediz Dalkılıç, Umut Kalyoncu, Rıdvan Mercan   +23 more
wiley   +1 more source

Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies

RMD Open
Objective To assess the impact of bimekizumab on physical functioning, sleep, work productivity and overall health-related quality of life (HRQoL) in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA) in the phase ...
Annelies Boonen, Atul Deodhar, Martin Rudwaleit, Lianne S Gensler, Karl Gaffney, Maureen Dubreuil, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Thomas Vaux, Michael F Mørup, Christine de la Loge   +12 more
doaj   +1 more source

Global Functioning in Axial Spondyloarthritis is Stronger Associated With Disease Activity and Function Than With Mobility and Radiographic Damage

Arthritis Care &Research, Volume 77, Issue 3, Page 385-392, March 2025.
Objective The Assessment of Spondyloarthritis International Society Health Index (ASAS HI) is a validated patient‐reported outcome (PRO) for global functioning of patients with axial spondyloarthritis (axSpA). The Epionics SPINE (ES) is an electronic device for assessment of axial mobility that provides an objective measure of spinal mobility by ...
David Kiefer, Jürgen Braun, Uta Kiltz, Varvara Chatzistefanidi, Daniela Adolf, Ilka Schwarze, Maria Kabelitz, Uwe Lange, Jan Brandt‐Jürgens, Edgar Stemmler, Sabine Sartingen, Xenofon Baraliakos   +11 more
wiley   +1 more source

Social role participation questionnaire for patients with ankylosing spondylitis: Translation into Dutch, reliability and construct validity [PDF]

, 2016
Objective: The Social Role Participation Questionnaire (SRPQ) assesses the influence of health on participation in 11 specific and one general participation role across 4 participation dimensions: 'importance', 'satisfaction with time', 'satisfaction ...
Arends, S. (Suzanne), Boonen, A. (Annelies), Gignac, M.A. (Monique), Heijde, D. (Desiree) van der, Heuft, L. (Liesbeth), Keszei, A.P. (András), Lacaille, D. (Diane), Landewé, R.B.M. (Robert), Luime, J.J. (Jolanda), Plasqui, G. (Guy), Spoorenberg, A. (A.), Van Gaalen, F. (Floris), Van Genderen, S. (Simon)   +12 more
core   +1 more source

Integration of Metabolomics and 16S Ribosomal RNA Sequencing to Elucidate the Pathogenesis of Ankylosing Spondylitis

Immunity, Inflammation and Disease, Volume 13, Issue 3, March 2025.
Disrupted gut microbiota and altered metabolites are present in AS patients. The analysis of microbiome and metabolomic data revealed significant differences between AS patients and HCs. ABSTRACT Objective Despite growing interest in the gut microbiota and blood metabolome in patients with ankylosing spondylitis (AS), its role remains poorly understood.
Xin Wang, Haojie Xu, Yuyan Chao, Chao Sun, Tingting Wang, Xiaoyun Fan, Lin Tang, Shengqian Xu, Changhao Xie   +8 more
wiley   +1 more source

Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis

Medicina, 2020
Background and objectives: The main objective of this study is to highlight the efficiency of different therapeutic means in patients with ankylosing spondylitis, resulting in the improvement of their quality of life.
Iulia Rahela Marcu, Dalia Dop, Vlad Padureanu, Stefan Adrian Niculescu, Rodica Padureanu, Carmen Elena Niculescu, Otilia Constantina Rogoveanu   +6 more
doaj   +1 more source

A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 3, Page 512-528, March 2025.
Abstract Background Gender‐ and sex‐specific differences in medicine were long‐time disregarded. Despite numerous indications of gender‐ and sex‐specific influences on the treatment of dermatological conditions, these have not yet been systematically investigated.
S. Preis, S. Ziehfreund, T. Biedermann, S. Horster, A. Zink   +4 more
wiley   +1 more source